Insights - Page 92 of 107 - LucidQuest Ventures

Hematology Weekly News - March 17th 2025

March 17, 2025Multiple Myeloma,blood cancer,BioPharma and Tech News,CAR T,Leukemiaanemia,Hematology News

🚀 Hematology News: Advancements in blood cancers, acute and chronic leukemias,…

by LucidQuest

Oncology Weekly Update - March 17th 2025

March 17, 2025cancer,cancer researchBioPharma and Tech News,Oncology News

🚀 Breaking Oncology News: NSCLC, Ovarian Cancer, PROTAC & New Approvals…

by LucidQuest

Obesity Weekly News - March 11th 2025

March 11, 2025clinical trials,wegovy,semaglutide,BioPharma and Tech News,Mounjaro,Obesity TreatmentWeight Loss Drugs,Obesity News

Obesity Drug Updates: Wegovy Price Drop, Mounjaro Expansion & New…

by LucidQuest

Cell and Gene Therapy Clinical Trials 2025 Edition

March 11, 2025Our Insightsbiotech,Oncology,clinical trials,CGT,cell and gene therapy

Introduction Cell and gene therapy (CGT) represents a groundbreaking frontier…

by Eugenia Tsempera

Hematology Weekly News - March 11th 2025

March 11, 2025biotech,precision medicine,FDA,BioPharma and Tech News,CAR T,LeukemiaBlood Disorders,Hematology News

🔬 Hematology Breakthroughs: Clinical trial results, new FDA approvals, and…

by LucidQuest

Oncology Weekly Update - March 10th 2025

March 10, 2025cancer research,fda approval,immunotherapy,BioPharma and Tech News,lung cancer,Ovarian Cancer,medical innovation,gastric cancer,esophageal cancerNSLC,Oncology News

🏥Oncology Update: Imfinzi, TEVIMBRA, Taletrectinib & New Trials Welcome to…

by LucidQuest

AAD 2025 Preview: Key Dermatology Highlights to Watch

March 7, 2025Conference Previews,AAD 2025Our Insights,inflammatory skin diseases,immunotherapy,remibrutinib,Atopic Dermatitis,vilobelimab,dermatology,risankizumab,psoriasis,actinic keratosis,melanoma,tirbanibulin,microbiome,deuruxolitinib,Bimekizumab,polynucleotides,Dupilumab,Abrocitinib,Alopecia Areata,hidradenitis suppurativa,Ritlecitinib,ruxolitinib

AAD 2025 at a glance With AAD 2025 on the horizon, here’s a preview of…

by LucidQuest

Obesity Weekly News - March 4th 2025

March 4, 2025clinical trials,Healthcare Innovation,BioPharma and Tech News,Obesity Research,Pharma News,Obesity TreatmentGLP1 updates,Obesity News

🔍 Breakthroughs in Obesity Treatment You Need to Know!…

by LucidQuest

Hematology Weekly News - March 3rd 2025

March 3, 2025Multiple Myeloma,blood cancer,BioPharma and Tech News,AML,hemophilia b,DLBCL,CLL,Medical Research,CMLfollicular lymphoma,Hematology News

🔬 Groundbreaking Advances in Hematology: AML, CML, CLL, multiple myeloma,…

by LucidQuest

Oncology Weekly Update - March 3rd 2025

March 3, 2025cancer research,fda approval,immunotherapy,prostate cancer,BioPharma and Tech News,lung cancer,Colorectal Cancer,Ovarian Cancermedical innovation,Oncology News

Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Vaccines & More This…

by LucidQuest

AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch

February 28, 2025Our Insights,immunotherapyimmunology,Asthma,Atopic Dermatitis,CRSwNP,allergy,Conference Previews,urticaria,AAAAI 2025,systemic mastocytosis,angioedema

AAAAI 2025 at a glance As AAAAI 2025 approaches, LucidQuest highlights…

by LucidQuest

Obesity Weekly News - Feb 25th 2025

February 25, 2025biotech,clinical trials,BioPharma and Tech News,glp1,Pharma News,Obesity TreatmentWeight Loss Drugs,Obesity News

🔬 Breakthroughs in Obesity Treatment: Latest Updates on GLP-1 Therapies &…

by LucidQuest

Minimize Uncertainty – Make Informed Decisions – Succeed